Echo Therapeutics calls on $5.5M in new funding

Thu, 01/06/2011 - 4:36am
Mass High Tech: The Journal of New England Technology

Echo Therapeutics Inc., a medical technology company making a needle-free monitoring and drug delivery system, has taken in $5.5 million in a set of new financing deals led by its majority shareholder Platinum Montaur Life Sciences LLC.

Franklin-based Echo Therapeutics (OTC Bulletin Board: ECTE) said it will use the new funds to boost product development, advance clinical studies and apply to “working capital and general corporate purposes.” The deal has two parts – a series of private stock placements that nets approximately $2.5 million for the company and a binding commitment for an additional $3 million. In addition to Montaur, other backers included current investors and unnamed institutional and accredited investors, according to the company.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.